HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of a human ovarian follicle isolation technique to obtain disease-free follicle suspensions before safely grafting to cancer patients.

AbstractOBJECTIVE:
To evaluate the safety of our follicle isolation procedure in a model of ovarian tissue artificially contaminated with cancer cells, then to improve the procedure to effectively eliminate malignant cells from follicle suspensions without altering viability.
DESIGN:
Prospective experimental study.
SETTING:
Gynecology research unit in a university hospital.
PATIENT(S):
Ten women undergoing laparoscopy for benign gynecologic disease.
INTERVENTION(S):
Follicle isolation from ovarian tissue artificially contaminated with marked fluorescent leukemic cells, either by the usual pickup technique without further treatment (group 1) or by washing three times after pickup (group 2).
MAIN OUTCOME MEASURE(S):
Evidence of leukemic cells in follicle suspensions using fluorescence microscopy and quantitative real-time polymerase chain reaction, and analysis of follicle viability.
RESULT(S):
In group 1, 196 leukemic cells were detected by fluorescence microscopy out of 499 follicles retrieved, while just one leukemic cell was found among 772 follicles after three washes. The BCR-ABL fusion transcript was detected when at least 19 cells were present in follicle suspensions; four samples were positive in group 1, and all were negative in group 2. Follicle viability was similar in both groups (95.6% vs. 96.4%).
CONCLUSION(S):
Cancer cells could inadvertently be picked up with isolated follicles in case of malignant contamination of ovarian tissue. A simple purging procedure consisting of three washes proved effective for eliminating leukemic cells while maintaining good follicle viability.
AuthorsMichelle Soares, Karima Sahrari, Christiani Andrade Amorim, Pascale Saussoy, Jacques Donnez, Marie-Madeleine Dolmans
JournalFertility and sterility (Fertil Steril) Vol. 104 Issue 3 Pg. 672-80.e2 (Sep 2015) ISSN: 1556-5653 [Electronic] United States
PMID26095134 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Chemical References
  • BCR-ABL1 fusion protein, human
  • Biomarkers, Tumor
  • RNA, Messenger
  • Fusion Proteins, bcr-abl
Topics
  • Adult
  • Biomarkers, Tumor (genetics)
  • Biopsy
  • Cell Line, Tumor
  • Cell Separation (methods)
  • Cell Survival
  • Female
  • Fertility Preservation (methods)
  • Fusion Proteins, bcr-abl (genetics)
  • Humans
  • Leukemia (genetics, pathology)
  • Microscopy, Fluorescence
  • Ovarian Follicle (pathology)
  • RNA, Messenger (genetics)
  • Real-Time Polymerase Chain Reaction
  • Reverse Transcriptase Polymerase Chain Reaction
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: